JP2022512539A5 - - Google Patents
Info
- Publication number
- JP2022512539A5 JP2022512539A5 JP2021511582A JP2021511582A JP2022512539A5 JP 2022512539 A5 JP2022512539 A5 JP 2022512539A5 JP 2021511582 A JP2021511582 A JP 2021511582A JP 2021511582 A JP2021511582 A JP 2021511582A JP 2022512539 A5 JP2022512539 A5 JP 2022512539A5
- Authority
- JP
- Japan
- Prior art keywords
- domain
- cancer
- binding
- pharmaceutical composition
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724592P | 2018-08-29 | 2018-08-29 | |
| US62/724,592 | 2018-08-29 | ||
| US201862734948P | 2018-09-21 | 2018-09-21 | |
| US62/734,948 | 2018-09-21 | ||
| US201962823994P | 2019-03-26 | 2019-03-26 | |
| US62/823,994 | 2019-03-26 | ||
| PCT/US2019/048919 WO2020047325A1 (en) | 2018-08-29 | 2019-08-29 | Combination therapies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022512539A JP2022512539A (ja) | 2022-02-07 |
| JP2022512539A5 true JP2022512539A5 (cg-RX-API-DMAC7.html) | 2022-09-06 |
Family
ID=69644804
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511582A Pending JP2022512539A (ja) | 2018-08-29 | 2019-08-29 | 併用療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20210324041A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3844177A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2022512539A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210068432A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112912384A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019333173A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021003683A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3109401A1 (cg-RX-API-DMAC7.html) |
| CO (1) | CO2021003136A2 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021002286A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020047325A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240141014A1 (en) * | 2021-03-03 | 2024-05-02 | Shattuck Labs, Inc. | Mutant pd-1 extracellular domains |
| WO2022212845A2 (en) * | 2021-04-01 | 2022-10-06 | Shattuck Labs, Inc. | Pd-1- and ox40l-based chimeric proteins |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8183207B2 (en) * | 2008-11-26 | 2012-05-22 | Five Prime Therapeutics, Inc. | Treatment of osteolytic disorders and cancer using CSF1R extracellular domain fusion molecules |
| JP6981973B2 (ja) * | 2015-10-01 | 2021-12-17 | ヒート バイオロジクス，インコーポレイテッド | Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法 |
| US20190367579A1 (en) * | 2017-02-27 | 2019-12-05 | Shattuck Labs, Inc. | Tigit- and light-based chimeric proteins |
-
2019
- 2019-08-29 EP EP19855957.7A patent/EP3844177A4/en not_active Withdrawn
- 2019-08-29 AU AU2019333173A patent/AU2019333173A1/en not_active Abandoned
- 2019-08-29 CA CA3109401A patent/CA3109401A1/en active Pending
- 2019-08-29 WO PCT/US2019/048919 patent/WO2020047325A1/en not_active Ceased
- 2019-08-29 BR BR112021003683-0A patent/BR112021003683A2/pt not_active Application Discontinuation
- 2019-08-29 CN CN201980068156.4A patent/CN112912384A/zh active Pending
- 2019-08-29 MX MX2021002286A patent/MX2021002286A/es unknown
- 2019-08-29 US US17/265,026 patent/US20210324041A1/en not_active Abandoned
- 2019-08-29 JP JP2021511582A patent/JP2022512539A/ja active Pending
- 2019-08-29 KR KR1020217009193A patent/KR20210068432A/ko not_active Withdrawn
-
2021
- 2021-03-10 CO CONC2021/0003136A patent/CO2021003136A2/es unknown